1. Bancroft J. Human sexuality and its problems. Edinburgh, London, New York, Oxford, Philadelphia, St Louis, Sydney, Toronto: Elsevier; 2009. p. 67–71 (sexual response) and 88–93 (orgasm).
2. Bishop JR, Moline J, Ellingrod VL, et al. Serotonin 2A-1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology. 2006;31(10):2281–8.
3. Zhang XR, Zhang ZJ, Zhu RX, et al. Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes. Pharmacogenomics. 2011;12(8):1127–36.
4. Goldberg JF, Ernst CL. Managing the side effects of psychotropic medications. Washington, DC: American Psychiatric Association Publishing; 2019. p. 218–44.
5. Stahl SM. Stahl’s essential psychopharmacology. Neuroscientific basis and practical applications. Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, São Paulo, Delhi: Cambridge University Press; 2008. p. 327–451.